Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Significance: Rheumatoid arthritis (RA) is a chronic, prevalent, and disabling autoimmune disease that occurs when inflammation damages joints. Recent advances in neuroscience and immunology have mapped neural circuits that regulate the onset and resolution of inflammation. In one circuit, termed “the inflammatory reflex,” action potentials transmitted in the vagus nerve inhibit the production of tumor necrosis factor (TNF), an inflammatory molecule that is a major therapeutic target in RA. Although studied in animal models of arthritis and other inflammatory diseases, whether electrical stimulation of the vagus nerve can inhibit TNF production in humans has remained unknown. The positive mechanistic results reported here extend the preclinical data to the clinic and reveal that vagus nerve stimulation inhibits TNF and attenuates disease severity in RA patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, VNS has been shown to inhibit peripheral blood production of TNF-α which is increased in clinical depression (10).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Current interfaces with the vagus nerve do not permit effective chronic stimulation or recording in mouse models, which is vital to studying the molecular and neurophysiological mechanisms that control inflammation homeostasis in health and disease.”
From A novel flexible cuff-like microelectrode for dual purpose, acute and chronic electrical interfacing with the mouse cervical vagus nerve (2017) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“These treatments have been shown to be beneficial in mood and anxiety disorders (7–9), but also in other conditions associated with increased inflammation (10).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [10]
In the citing paper
“This study was also the first to show that VNS inhibits the production of TNF-α and other cytokines in humans by stimulating the inflammatory reflex, leading to an improvement of symptom severity.”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [10]
In the citing paper
“In patients with rheumatoid arthritis, a study that demonstrated an improvement of symptoms in the early and late stages of the disease through 1–4 min of VNS daily (10).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Self-citationThe Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Self-citationEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
Rosas-Ballina, M., Olofsson, P. S., Ochani, M., Valdés-Ferrer, S. I., Levine, Y. A., Reardon, C., Tusche, M. W., Pavlov, V. A., Andersson, U., Chavan, S., et al. (2011) · Science · doi:10.1126/science.1209985 · Cited by 1,551
Self-citationHochberg, M. C., Chang, R. W., Dwosh, I., Lindsey, S., Pincus, T., & Wolfe, F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350502 · Cited by 879
The Disease Activity Score and the EULAR Response Criteria
Fransen, J., & van Riel, P. L. C. M. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.10.001 · Cited by 877 · cited 2×
“At that visit the frequency of daily stimulation events was increased to four times daily in patients who had not achieved a moderate or good clinical response according EULAR criteria (24).”
BackgroundHuston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052362 · Cited by 683
Self-citationChronic vagus nerve stimulation in Crohn's disease: a 6‐month follow‐up pilot study
Bonaz, B., Sinniger, V., Hoffmann, D., Clarençon, D., Mathieu, N., Dantzer, C., Vercueil, L., Picq, C., Trocmé, C., Faure, P., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12792 · Cited by 492 · cited 3×
“patients receiving prior nonbiologic disease-modifying antirheumatic drugs (%) 0 drugs 1 (13) 1 (10) 2 (11) 1 drug 2 (25) 3 (30) 5 (28) 2 drugs 2 (25) 2 (20) 4 (22) 3 or more drugs 3 (37) 4 (40) 7 (39) No.”
ResultReflex principles of immunological homeostasis
Andersson, U., & Tracey, K. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075015 · Cited by 414 · cited 1×
“Recent advances at the intersection of immunology and neuroscience reveal reflex neural circuit mechanisms regulating innate and adaptive immunity (7, 8).”
BackgroundSelf-citationVagus nerve stimulation, side effects, and long-term safety
Ben-Menachem, E. (2001) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200109000-00005 · Cited by 400 · cited 4×
“patients receiving prior nonbiologic disease-modifying antirheumatic drugs (%) 0 drugs 1 (13) 1 (10) 2 (11) 1 drug 2 (25) 3 (30) 5 (28) 2 drugs 2 (25) 2 (20) 4 (22) 3 or more drugs 3 (37) 4 (40) 7 (39) No.”
BackgroundInfluentialNeural reflexes in inflammation and immunity
Andersson, U., & Tracey, K. J. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120571 · Cited by 378 · cited 3×
“Acetylcholine is the cognate ligand for α-7 nicotinic acetylcholine receptors (α7nAChR) expressed on cytokine-producing monocytes, macrophages, and stromal cells (7, 10, 11).”
BackgroundSelf-citationAnti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease
Meregnani, J., Clarençon, D., Vivier, M., Peinnequin, A., Mouret, C., Sinniger, V., Picq, C., Job, A., Canini, F., Jacquier-Sarlin, M., et al. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.10.007 · Cited by 310
Huston, J. M., Gallowitsch-Puerta, M., Ochani, M., Ochani, K., Yuan, R., Rosas-Ballina, M., Ashok, M., Goldstein, R. S., Chavan, S., Pavlov, V. A., et al. (2007) · Critical Care Medicine · doi:10.1097/00003246-200712000-00014 · Cited by 306 · cited 1×
“Endotoxin was added to the whole blood to stimulate the production of TNF by monocytes for 4 h (13, 23).”
MethodSelf-citationStimulation of nicotinic acetylcholine receptors attenuates collagen‐induced arthritis in mice
van Maanen, M. A., Lebre, M. C., van der Poll, T., LaRosa, G. J., Elbaum, D., Vervoordeldonk, M. J., & Tak, P. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24177 · Cited by 274 · cited 2×
“In experimental collageninduced arthritis, vagotomy or selective disruption of α7nAChR worsened disease severity, and administration of nicotine or other selective α7nAChR agonists, ameliorated disease severity (17, 18).”
BackgroundSelf-citationSocietal cost of rheumatoid arthritis patients in the US
Birnbaum, H., Pike, C., Kaufman, R., Maynchenko, M., Kidolezi, Y., & Cifaldi, M. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903422307 · Cited by 238 · cited 1×
“3 million adult cases in the United States, with attributable medical costs estimated between $19–39 billion (2, 3).”
BackgroundOverview of the Clinical Applications of Vagus Nerve Stimulation
Beekwilder, J. P., & Beems, T. (2010) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e3181d64d8a · Cited by 215 · cited 2×
“Vagus nerve stimulation has been used to treat medically refractory epilepsy in more than 100,000 patients, and it is generally well tolerated (21, 22).”
BackgroundLu, B., Kwan, K., Levine, Y. A., Olofsson, P. S., Yang, H., Li, J., Joshi, S., Wang, H., Andersson, U., Chavan, S. S., et al. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00117 · Cited by 206 · cited 2×
“patients receiving prior biologic disease-modifying antirheumatic drugs (%) 0 drugs 3 (38) 0 3 (17) 1 drug 4 (50) 0 4 (22) 2 drugs 1 (12) 0 1 (6) 3 drugs 0 3 (30) 3 (17) 4 drugs 0 4 (40) 4 (22) 5 drugs 0 2 (20) 2 (11) 6 drugs 0 1 (10) 1 (6) DAS28-CRP (SD) 6.”
BackgroundSelf-citationLevine, Y. A., Koopman, F. A., Faltys, M., Caravaca, A., Bendele, A., Zitnik, R., Vervoordeldonk, M. J., & Tak, P. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104530 · Cited by 202 · cited 2×
“The electrical stimulation parameters used in this study were previously established to stimulate the inflammatory reflex in preclinical studies and differ significantly from the stimulation protocols used in epilepsy (19, 27).”
BackgroundMethodSelf-citationChorus, A. M. J., Miedema, H. S., Boonen, A., & van der Linden, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.004861 · Cited by 196 · cited 3×
“Neurogastroenterol Motil 28(6):948–953.”
BackgroundRosas-Ballina, M., Goldstein, R. S., Gallowitsch-Puerta, M., Yang, L., Valdés-Ferrer, S. I., Patel, N. B., Chavan, S., Al-Abed, Y., Yang, H., & Tracey, K. J. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00039 · Cited by 195 · cited 3×
“Endotoxin was added to the whole blood to stimulate the production of TNF by monocytes for 4 h (13, 23).”
BackgroundMethodSelf-citationFransen, J., Stucki, G., & van Riel, P. L. C. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11407 · Cited by 192 · cited 3×
“The primary study endpointwasmean change in theDAS28-CRPbetween visits on baseline day −21 and day 42 (25).”
BackgroundMethodAdvances in rheumatology: new targeted therapeutics
Tak, P. P., & Kalden, J. R. (2011) · Arthritis Research & Therapy · doi:10.1186/1478-6354-13-s1-s5 · Cited by 190
Self-citationGerlag, D. M., Haringman, J. J., Smeets, T. J. M., Zwinderman, A. H., Kraan, M. C., Laud, P. J., Morgan, S. R., Nash, A., & Tak, P. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20664 · Cited by 170 · cited 1×
“It has been established previously that biomarkers are not modifiable by placebo effects in RA studies of this duration (28, 29).”
BackgroundSelf-citationvan Maanen, M. A., Stoof, S. P., LaRosa, G. J., Vervoordeldonk, M. J., & Tak, P. P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118554 · Cited by 163
Self-citationThe cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis
van Maanen, M. A., Vervoordeldonk, M. J., & Tak, P. P. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.31 · Cited by 147 · cited 4×
“patients receiving prior nonbiologic disease-modifying antirheumatic drugs (%) 0 drugs 1 (13) 1 (10) 2 (11) 1 drug 2 (25) 3 (30) 5 (28) 2 drugs 2 (25) 2 (20) 4 (22) 3 or more drugs 3 (37) 4 (40) 7 (39) No.”
BackgroundInfluentialSelf-citationAutonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study
Koopman, F. A., Tang, M. W., Vermeij, J., de Hair, M. J., Choi, I. Y., Vervoordeldonk, M. J., Gerlag, D. M., Karemaker, J. M., & Tak, P. P. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.029 · Cited by 117 · cited 1×
“Finally, our recent prospective observational studies indicate that impaired constitutive vagus nerve activity precedes the development of clinically manifest RA (31).”
BackgroundSelf-citationAcetylcholine regulation of synoviocyte cytokine expression by the α7 nicotinic receptor
Waldburger, J., Boyle, D. L., Pavlov, V. A., Tracey, K. J., & Firestein, G. S. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23987 · Cited by 102 · cited 3×
“Acetylcholine is the cognate ligand for α-7 nicotinic acetylcholine receptors (α7nAChR) expressed on cytokine-producing monocytes, macrophages, and stromal cells (7, 10, 11).”
BackgroundSelf-citationBruchfeld, A., Goldstein, R. S., Chavan, S., Patel, N. B., Rosas‐Ballina, M., Kohn, N., Qureshi, A. R., & Tracey, K. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02226.x · Cited by 99 · cited 1×
“The LPS-induced cytokine release assay was performed as previously described (33).”
MethodSelf-citationMaanen, M. A. V., Stoof, S. P., Zanden, E. P. V. D., Jonge, W. J. D., Janssen, R. A., Fischer, D. F., Vandeghinste, N., Brys, R., Vervoordeldonk, M. J., & Tak, P. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24470 · Cited by 84 · cited 3×
“Acetylcholine is the cognate ligand for α-7 nicotinic acetylcholine receptors (α7nAChR) expressed on cytokine-producing monocytes, macrophages, and stromal cells (7, 10, 11).”
Self-citationOlofsson, P. S., Levine, Y. A., Caravaca, A., Chavan, S. S., Pavlov, V. A., Faltys, M., & Tracey, K. J. (2015) · Bioelectronic Medicine · doi:10.15424/bioelectronmed.2015.00006 · Cited by 81 · cited 1×
“The electrical stimulation parameters used in this study were previously established to stimulate the inflammatory reflex in preclinical studies and differ significantly from the stimulation protocols used in epilepsy (19, 27).”
MethodSelf-citationTracey, K. J. (2015) · Scientific American · doi:10.1038/scientificamerican0315-28 · Cited by 31
Self-citationWhy Girls are Starting Puberty Early
Maron, D. F. (2015) · Scientific American · doi:10.1038/scientificamerican0515-28 · Cited by 19
Choi, I. Y. K., Gerlag, D. M., Holzinger, D., Roth, J., & Tak, P. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106253 · Cited by 18 · cited 2×
“patients receiving prior nonbiologic disease-modifying antirheumatic drugs (%) 0 drugs 1 (13) 1 (10) 2 (11) 1 drug 2 (25) 3 (30) 5 (28) 2 drugs 2 (25) 2 (20) 4 (22) 3 or more drugs 3 (37) 4 (40) 7 (39) No.”
BackgroundSelf-citationLevine, Y. A., Koopman, F. A., Faltys, M. A., Zitnik, R. J., & Tak, P. P. (2014) · Bioelectronic Medicine · doi:10.15424/bioelectronmed.2014.00008 · Cited by 14
Self-citation
Cited by
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
“Vagal stimulation reduces arthritic joint inflammation in humans (147), and vagotomy in mice reduces pro-resolving mediators (i.”
BackgroundVagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“In patients with rheumatoid arthritis, a study that demonstrated an improvement of symptoms in the early and late stages of the disease through 1–4 min of VNS daily (10).”
BackgroundInfluentialThe immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
The pathogenesis of rheumatoid arthritis
Alivernini, S., Firestein, G. S., & McInnes, I. B. (2022) · Immunity · doi:10.1016/j.immuni.2022.11.009 · Cited by 702
Metadata
- Authors
- Koopman, F. A., Chavan, S. S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P. R., Mehta, A. D., Levine, Y. A., Faltys, M., Zitnik, R., Tracey, K. J., & Tak, P. P.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Feinstein Institute for Medical Research (US)
- University Clinical Hospital Mostar (BA)
- Sisters of Charity Hospital (HR)
- Sarajevo University Clinical Center, Sarajevo 71000, Bosnia and Herzegovina;
- Hofstra University (US)
- SetPoint Medical Corporation, Valencia, CA91355
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-07-05
- Volume
- 113
- Issue
- 29
- Pages
- 8284-8289
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4961187
- OpenAlex
- W2469268362
- Cited by
- 1,024
- References
- 38
- Citations by year
- 2026: 92 · 2025: 97 · 2024: 104 · 2023: 96 · 2022: 126 · 2021: 123 · 2020: 109 · 2019: 101 · 2018: 91 · 2017: 70 · 2016: 13
- FWCI
- 50.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- vagus nerve stimulation, rheumatoid arthritis, cholinergic anti-inflammatory pathway, TNF-α, IL-1β, interleukin-6, cytokine production, neuromodulation, epilepsy patients, autoimmune disease, inflammation
- MeSH terms
- Adult, Aged, Arthritis, Rheumatoid, Epilepsy, Female, Humans, Male, Middle Aged, Cytokines, Vagus Nerve Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.